Mark A. Velleca insider trades

Open-market stock purchases and sales by Mark A. Velleca, PRESIDENT & CEO at Black Diamond Therapeutics, Inc, from SEC Form 4 filings since Dec 18, 2017.

Recent trades

DateStockTradeValue
Jan 21, 2026BDTX Black Diamond Therapeutics, IncBought (not open market)—

Companies traded

  • BDTX Black Diamond Therapeutics, Inc: other filings, last Jan 21, 2026
  • GTHX G1 Therapeutics, Inc: 48 sales, last Aug 8, 2023

Get free alerts when Mark A. Velleca files a new trade →